Search results
Usher says early detection could have better prepared his family for a Type 1 diabetes diagnosis—97%...
CNBC· 4 days agoWhen Usher isn't on stage belting ballads and putting on a show, he's doing all that he can to...
Essential signs of child type 2 diabetes all parents need to know
Rolling Out· 2 days agoChildhood type 2 diabetes is a growing concern worldwide. Unlike type 1 diabetes, which is often ...
Usher and Apple CEO Tim Cook had a meeting. Now the Super Bowl performer is taking his ideas to...
Fortune via AOL· 4 days agoThe mission is not new for the singer; last year, Usher and Sanofi launched the "The 1 Pledge," a...
12 Celebrities Living With Diabetes
SheKnows via Yahoo News· 2 days agoIt shouldn’t come as a surprise that some of your favorite celebrities are among the over 29 million people across the country living with diabetes. ...
Will FLiRT COVID variants bring another summer surge? What to know about symptoms and potential for...
Fortune via Yahoo Finance· 4 days ago...following conditions are at high risk of severe COVID-19 infection and may need additional...
Dexcom's blood sugar monitors now sync directly with your Apple Watch — here's why it's a big deal
Tom's Guide· 4 days agoWhile it would be a game-changer if the Apple Watch could read blood sugar levels on its own, users...
Ozempic vs. metformin: What’s the difference?
Medical News Today· 7 days agoOzempic (semaglutide) is a brand-name drug, while metformin is a generic drug. This article explains the main similarities and differences between...
Ozempic Just Got Even More Bullish For Novo Nordisk Stock, Yet Again
Motley Fool via Yahoo Finance· 3 days agoSo, if there were a medicine that was known to be helpful in treating type 2 diabetes and reducing...
Everything You Need to Know About Metabolic Acidosis
Verywell Health via Yahoo News· 3 days agoMetabolic acidosis is a condition in which acid builds up in the body due to a problem in your cells that throws off the chemical balance in your blood....
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
StreetInsider· 5 hours agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate ...